Skip to main content
Livermore
Livermore
ZHEN

Cito Capital Group, LLC

SEC CIK
0001722439
Latest filing
Aug 14, 2026

ABBV holding history

AbbVie Inc. in every 13F filed by Cito Capital Group, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ABBV overviewAll 13F holders of ABBVFull Q2 2026 holdings

Shares (Q2 2026)
20,290
Value
$5.11M
% of portfolio
1.4%
Quarters held
22
Since Q1 2021
Holdings of ABBV by Cito Capital Group, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202620,290$5.11M1.4%+100.0%AddedHolders
Q1 202620,280$4.41M1.4%+810+4.2%AddedHolders
Q4 202519,470$4.45M1.3%+70.0%AddedHolders
Q3 202519,463$4.51M1.3%+11+0.1%AddedHolders
Q2 202519,452$3.61M1.3%+360+1.9%AddedHolders
Q1 202519,092$4.00M1.5%+10+0.1%AddedHolders
Q4 202419,082$3.39M1.2%+210+1.1%AddedHolders
Q3 202418,872$3.73M1.4%−1,790−8.7%ReducedHolders
Q2 202420,662$3.54M1.4%+11+0.1%AddedHolders
Q1 202420,651$3.76M1.5%+11+0.1%AddedHolders
Q4 202320,640$3.20M1.4%+12+0.1%AddedHolders
Q3 202320,628$3.08M1.5%+1,710+9.0%AddedHolders
Q2 202318,918$2.55M1.2%+12+0.1%AddedHolders
Q1 202318,906$3.01M1.5%+10+0.1%AddedHolders
Q4 202218,896$3.05M1.7%+62+0.3%AddedHolders
Q3 202218,834$2.53M1.4%+10+0.1%AddedHolders
Q2 202218,824$2.88M1.6%+10+0.1%AddedHolders
Q1 202218,814$3.05M1.4%−489−2.5%ReducedHolders
Q4 202119,303$2.61M1.1%+11+0.1%AddedHolders
Q3 202119,292$2.08M1.0%−6,488−25.2%ReducedHolders
Q2 202125,780$2.90M1.3%+110.0%AddedHolders
Q1 202125,769$2.79M1.4%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.